Browsing by Author "301ed676-233e-46ce-bc26-8f8c5b6aa143"

Now showing items 1-2 of 2

    • A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the ... 
      Burmester, Gerd R.; McInnes, Iain B.; Kremer, Joel; Miranda, Pedro; Korkosz, Mariusz; Vencovsky, Jiri; Rubbert-Roth, Andrea; Mysler, Eduardo; Sleeman, Matthew A.; Godwood, Alex; Sinibaldi, Dominic; Guo, Xiang; White, Wendy I.; Wang, Bing; Wu, Chi Yuan; Ryan, Patricia C. (BMJ Publishing Group, 2017)
      Objectives: Despite the therapeutic value of current rheumatoid arthritis (RA) treatments, agents with alternative modes of action are required. Mavrilimumab, a fully human monoclonal antibody targeting the granulocyte-macrophage ...
    • A randomized phase IIb study of mavrilimumab and golimumab in Rheumatoid Arthritis 
      Weinblatt, Michael E.; McInnes, Iain B.; Kremer, Joel M.; Miranda, Pedro; Vencovsky, Jiri; Guo, Xiang; White, Wendy I.; Ryan, Patricia C.; Godwood, Alex; Albulescu, Marius; Close, David; Burmester, Gerd R. (Wiley, 2018)
      ObjectiveThis 24-week, phase IIb, double-blind study was undertaken to evaluate the efficacy and safety of mavrilimumab (a monoclonal antibody to granulocyte-macrophage colony-stimulating factor receptor ) and golimumab ...